Barclays’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.19M Sell
67,447
-14,343
-18% -$1.12M ﹤0.01% 1798
2025
Q4
$6.46M Buy
81,790
+1,759
+2% +$152K ﹤0.01% 2023
2025
Q3
$7.33M Sell
80,031
-104,608
-57% -$8.53M ﹤0.01% 1915
2025
Q2
$12M Buy
184,639
+45,359
+33% +$2.95M ﹤0.01% 1441
2025
Q1
$9.32M Sell
139,280
-17,780
-11% -$1.06M ﹤0.01% 1458
2024
Q4
$8.68M Buy
157,060
+14,027
+10% +$805K ﹤0.01% 1679
2024
Q3
$8.53M Buy
143,033
+135,003
+1,681% +$8.24M ﹤0.01% 1594
2024
Q2
$511K Sell
8,030
-6,852
-46% -$445K ﹤0.01% 3032
2024
Q1
$1.03M Sell
14,882
-10,383
-41% -$627K ﹤0.01% 3099
2023
Q4
$1.39M Buy
25,265
+15,944
+171% +$878K ﹤0.01% 3201
2023
Q3
$541K Buy
9,321
+1,682
+22% +$97.1K ﹤0.01% 2758
2023
Q2
$411K Buy
7,639
+498
+7% +$22.1K ﹤0.01% 2880
2023
Q1
$284K Buy
7,141
+595
+9% +$25.1K ﹤0.01% 3608
2022
Q4
$263K Buy
6,546
+2,193
+50% +$82.4K ﹤0.01% 3697
2022
Q3
$140K Sell
4,353
-2,999
-41% -$103K ﹤0.01% 3377
2022
Q2
$218K Sell
7,352
-4,460
-38% -$129K ﹤0.01% 3375
2022
Q1
$331K Sell
11,812
-4,154
-26% -$155K ﹤0.01% 3147
2021
Q4
$736K Buy
15,966
+8,190
+105% +$352K ﹤0.01% 3005
2021
Q3
$255K Buy
7,776
+2,525
+48% +$78.5K ﹤0.01% 3494
2021
Q2
$185K Sell
5,251
-11,365
-68% -$387K ﹤0.01% 3590
2021
Q1
$601K Buy
16,616
+1,230
+8% +$38.5K ﹤0.01% 3078
2020
Q4
$447K Sell
15,386
-995
-6% -$28.5K ﹤0.01% 3307
2020
Q3
$462K Buy
16,381
+2,988
+22% +$89K ﹤0.01% 3289
2020
Q2
$433K Buy
13,393
+916
+7% +$32.8K ﹤0.01% 3450
2020
Q1
$509K Sell
12,477
-1,336
-10% -$71.1K ﹤0.01% 3571
2019
Q4
$852K Buy
13,813
+4,626
+50% +$306K ﹤0.01% 3817
2019
Q3
$669K Sell
9,187
-3,275
-26% -$245K ﹤0.01% 4002
2019
Q2
$1.02M Sell
12,462
-11,453
-48% -$815K ﹤0.01% 3656
2019
Q1
$1.69M Sell
23,915
-268
-1% -$15.8K ﹤0.01% 2753
2018
Q4
$1.09M Buy
24,183
+8,834
+58% +$463K ﹤0.01% 3029
2018
Q3
$868K Buy
15,349
+5,381
+54% +$329K ﹤0.01% 3767
2018
Q2
$665K Sell
9,968
-1,292
-11% -$80.7K ﹤0.01% 3678
2018
Q1
$655K Buy
11,260
+685
+6% +$43.5K ﹤0.01% 3676
2017
Q4
$681K Buy
10,575
+3,715
+54% +$231K ﹤0.01% 3507
2017
Q3
$361K Buy
6,860
+3,078
+81% +$147K ﹤0.01% 3911
2017
Q2
$176K Sell
3,782
-1,815
-32% -$87.6K ﹤0.01% 4473
2017
Q1
$277K Sell
5,597
-3,670
-40% -$206K ﹤0.01% 4002
2016
Q4
$562K Buy
9,267
+5,931
+178% +$363K ﹤0.01% 3268
2016
Q3
$221K Sell
3,336
-17,931
-84% -$1.12M ﹤0.01% 3890
2016
Q2
$1.19M Buy
21,267
+9,852
+86% +$479K ﹤0.01% 2463
2016
Q1
$378K Sell
11,415
-14,654
-56% -$497K ﹤0.01% 3354
2015
Q4
$1.17M Buy
26,069
+9,707
+59% +$418K ﹤0.01% 2470
2015
Q3
$639K Buy
16,362
+3,235
+25% +$184K ﹤0.01% 3132
2015
Q2
$813K Sell
13,127
-7,511
-36% -$447K ﹤0.01% 3070
2015
Q1
$1.28M Buy
20,638
+19,703
+2,107% +$1.2M ﹤0.01% 2744
2014
Q4
$52K Sell
935
-3,181
-77% -$140K ﹤0.01% 5680
2014
Q3
$115K Buy
4,116
+3,588
+680% +$108K ﹤0.01% 5214
2014
Q2
$18K Sell
528
-849
-62% -$26.6K ﹤0.01% 6555
2014
Q1
$43K Buy
1,377
+732
+113% +$19.4K ﹤0.01% 6112
2013
Q4
$13K Sell
645
-16
-2% -$207 ﹤0.01% 6894
2013
Q3
$6K Sell
661
-150
-18% -$1.08K ﹤0.01% 6925
2013
Q2
$5K Buy
+811
New +$5.67K ﹤0.01% 7344

Other funds holding ANIP